KRAS and lung cancer: In addition, we observed that pyrvinium could cause the accumulation of ROS in Molm13 cells, and it has been reported to selectively trigger the ROS release and mitochondrial membrane depolarization, as well as inhibit aerobic glycolysis in KRAS-mutant lung cancer cells [50].